Morocco has been a recipient country of the Global Fund since 2003 and has signed over US$129 million of grants for HIV, TB, TB/HIV and RSSH programmes. Morocco is also part of the Multicountry MENA HRA and Multicountry MENA Key Populations Multicountry MENA grants supported by the Global Fund.
In 2003, Morocco was the first country in the Middle East and North Africa region to sign a partnership with the Global Fund. In addition to public-sector actors, with the Ministry of Health at the forefront, this agreement also allowed for greater civil society involvement in combating the epidemics in the country.
As of 2019, In Morocco, the number of people receiving antiretroviral treatment increased by a factor of 50 between 2003 and 2017; the number of new infections dropped by almost 25% between 2010 and 2018. As for tuberculosis, the mortality rate dropped by 59% between 1990 and 2017; the number of new infections fell by 27%; and the detection rate is now 86%. Morocco eliminated malaria in 2010, and treatment of the disease is now limited to a few imported cases.